1 Ocak 2020 Dergi makalesi Açık Erişim

Temel, Sehime Gulsun; Giray, Asli; Karakas, Bahriye; Gul, Ozgur; Kozanoglu, Ilknur; Celik, Husnu; Basaga, Huveyda; Acikbas, Ufuk; Sucularli, Ceren; Oztop, Sidika; Aka, Yeliz; Kutuk, Ozgur

MARC21 XML

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Giray, Asli</subfield>
    <subfield code="u">Alanya Alaaddin Keykubat Univ, Dept Genet &amp; Bioengn, Alanya, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Karakas, Bahriye</subfield>
    <subfield code="u">Sabanci Univ, Mol Biol Genet &amp; Bioengn Program, Istanbul, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Gul, Ozgur</subfield>
    <subfield code="u">Bilgi Univ, Dept Genet &amp; Bioengn, Istanbul, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Kozanoglu, Ilknur</subfield>
    <subfield code="u">Baskent Univ, Adana Dr Turgut Noyan Med &amp; Res Ctr, Dept Physiol, Adana, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Celik, Husnu</subfield>
    <subfield code="u">Baskent Univ, Adana Dr Turgut Noyan Med &amp; Res Ctr, Dept Obstet &amp; Gynecol, Adana, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Basaga, Huveyda</subfield>
    <subfield code="u">Sabanci Univ, Mol Biol Genet &amp; Bioengn Program, Istanbul, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Acikbas, Ufuk</subfield>
    <subfield code="u">Baskent Univ, Adana Dr Turgut Noyan Med &amp; Res Ctr, Dept Immunol, Adana, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Sucularli, Ceren</subfield>
    <subfield code="u">Hacettepe Univ, Inst Hlth Sci, Dept Bioinformat, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Oztop, Sidika</subfield>
    <subfield code="u">Baskent Univ, Adana Dr Turgut Noyan Med &amp; Res Ctr, Dept Immunol, Adana, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Aka, Yeliz</subfield>
    <subfield code="u">Baskent Univ, Adana Dr Turgut Noyan Med &amp; Res Ctr, Dept Immunol, Adana, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Kutuk, Ozgur</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="4">
    <subfield code="p">APOPTOSIS</subfield>
    <subfield code="v">25</subfield>
    <subfield code="n">11-12</subfield>
    <subfield code="c">799-816</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="a">Creative Commons Attribution</subfield>
    <subfield code="u">http://www.opendefinition.org/licenses/cc-by</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.1007/s10495-020-01635-z</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">RAB25 confers resistance to chemotherapy by altering mitochondrial apoptosis signaling in ovarian cancer cells</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Temel, Sehime Gulsun</subfield>
    <subfield code="u">Uludag Univ, Sch Med, Dept Med Genet, Bursa, Turkey</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="o">oai:zenodo.org:6503</subfield>
    <subfield code="p">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="2">opendefinition.org</subfield>
    <subfield code="a">cc-by</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2020-01-01</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="u">https://aperta.ulakbim.gov.trrecord/6503/files/bib-f271491c-8815-4141-928a-f41fcedb8ce3.txt</subfield>
    <subfield code="z">md5:e82cd760403b768ff5e39884d9c44214</subfield>
    <subfield code="s">291</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <controlfield tag="005">20210315062639.0</controlfield>
  <controlfield tag="001">6503</controlfield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Ovarian cancer remains one of the most frequent causes of cancer-related death in women. Many patients with ovarian cancer suffer from de novo or acquired resistance to chemotherapy. Here, we report that RAB25 suppresses chemotherapy-induced mitochondrial apoptosis signaling in ovarian cancer cell lines and primary ovarian cancer cells. RAB25 blocks chemotherapy-induced apoptosis upstream of mitochondrial outer membrane permeabilization by either increasing antiapoptotic BCL-2 proteins or decreasing proapoptotic BCL-2 proteins. In particular, BAX expression negatively correlates with RAB25 expression in ovarian cancer cells. BH3 profiling assays corroborated that RAB25 decreases mitochondrial cell death priming. Suppressing RAB25 by means of RNAi or RFP14 inhibitory hydrocarbon-stapled peptide sensitizes ovarian cancer cells to chemotherapy as well as RAB25-mediated proliferation, invasion and migration. Our data suggest that RAB25 is a potential therapeutic target for ovarian cancer.</subfield>
  </datafield>
</record>